NKX2-1 expression as a prognostic marker in early-stage non-small-cell lung cancer.

BMC Pulm Med · 2017 · PMC5727907 · PMID 29237428

Europe PMC DOI

hedged sentence

0.0730

closest p · 1.5× alpha

0.0730

boldest claim

The sentences

showed a trendP = 0.073so close (0.05 < p ≤ 0.1)

Patients with high levels of miR-365 showed a trend toward shorter OS than those with high levels (entire cohort: 60.9 vs 79.2 moths, P = 0.073; Stage I disease: 58.3 vs 76.6 months, P = 0.118; Additional file 1 : Figure S3).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.